Scope of Congress
Program Overview
SEP. 18, 2016
SEP. 19, 2016
SEP. 20, 2016
SEP. 21, 2016
SEP. 22, 2016

SUNDAY, SEP. 18, 2016
Click here to download the program
Registration 08:00-19:30 @ Lobby, 1F
Speaker Ready Room 08:00-19:30 @ 103, 1F
09:00-17:30 Bioinformatics Hub Click here for more information
  • Location: Room 203, 2F
09:00-15:00 Clinical Day - Clinical Proteomics for Precision Medicine (Ticketed Session)
  • Location: Room 101C, 1F
  • Organizers: Christoph Borchers, Yu-Ju Chen
  • Morning Coffee and Lunch will be provided.
  • Click here for a full program
09:00-15:30 Education Day - Refresher on Biology & Medicine (Ticketed Session)
  • Location: Room 101A, 1F
  • Organizers: Garry Corthals, Tove Alm
  • Morning Coffee and Lunch will be provided.
  • Click here for a full program
09:00-15:30 Mentoring Day (Ticketed Session)
  • Location: Room 101D, 1F
  • Organizers: Justyna Fert-Bober, Burcu Ayoglu, Ferdinando Cerciello
  • Morning Coffee and Lunch will be provided.
  • Click here for a full program
09:00 - 15:30 Technology Day
  • Location: Room 102, 1F
  • Organizers: Robert Moritz, Yu-Ju Chen
  • Morning coffee will be provided.
  • Click here for a full program
09:00-15:20 HPP Investigator’s Meeting
  • Organizers: Fernando J. Corrales, Young-Ki Paik, Gilbert S. Omenn
  • Morning Coffee and Lunch will be provided.
  • Plenary Session: Room 101B, 1F
  • Break-out session: Room 101B, 202A, South Lounge
  • Click here for a full program
15:45-17:45 HUPO Council Meeting
  • Location: Room 401, 4F
18:00-18:30 Opening Ceremony
  • Location: Plenary Hall, 3F
18:30-19:15 Opening Plenary Session: Managing Health and Understanding Disease Using Big Data
  • Location: Plenary Hall, 3F
  • Speaker: Michael Snyder, Stanford University School of Medicine, USA
19:15-20:00 Opening Plenary Session: Precision Lung Cancer Therapy: Current and Beyond
  • Location: Plenary Hall, 3F
  • Speaker: Pan-Chyr Yang, National Taiwan University, Taiwan
20:00-21:30 Welcome Reception
  • Location: Room 201, 2F & Banquet Hall, 3F

MONDAY, SEP. 19, 2016
Click here to download the program.
Registration 08:00-17:30 @Lobby, 1F
Speaker Ready Room 08:00-17:30 @103, 1F
09:00-17:30 Bioinformatics Hub Click here for more information
  • Room: 203, 2F
Plenary Session: The Proteome in Context
  • Room: Plenary Hall, 3F
  • Speaker: Ruedi Aebersold, Institute of Molecular Systems Biology - ETH Zurich, Switzerland
09:30-10:30 Networking Break and Poster Viewing
Keynote Session: Cancer & Translational Proteomics
  • Room: Plenary Hall, 3F
[MK-01] iMALDI for Accurate Quantitation of the Expression and Phosphorylation Level of Akt in tumour Biopsies - Christoph H. Borchers, Canada
[MK-02] Verification of Oral Cancer Biomarkers and Their Translation to Clinical Settings - Jau-Song Yu, Taiwan
[MO01-001] Verification of Colorectal Cancer Biomarker Candidates in Plasma/Serum Extracellular Vesicles by Targeted Proteomics - Takeshi Tomonaga, Japan
[MO01-002] Proteomic Multimarker Panel Complements CA19-9 Insufficiency in the Diagnosis of Pancreatic Ductal Adenocarcinoma - Youngsoo Kim, South Korea
[MO01-003] Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment - Stephen Pennington, Ireland
[MO01-004] Tissue Derived Neo-Antigens for T Cell-Based Cancer Immunotherapy - Michal Bassani, Switzerland
[MO01-005] LinkedOmics: Discovering Associations Between Genomic, Proteomic and Clinical Attributes In Human Cancer - Jing Wang, United States
Keynote Session: Innovative MS Techniques for Global & Targeted Proteomics
  • Room: 101 AB, 1F
[MK-03] Comprehensive Analysis of Human Proteomes with Similar Depth as RNA-Seq -
Jesper Velgaard Olsen, Denmark
[MK-04] Comprehensive DIA with High Precursor Selectivity: How Can We Have Our Cake and Eat It Too? - Michael Maccoss, United States
[MO02-001] MS1 Based Quantification Optimization on DIA Methods on  a Quadrupole-Orbitrap mass spectrometer - Yue Xuan, Germany
[MO02-002] Digging Deeper Into Large SWATH MS1 Windows Using Gas Phase Fractionation SWATH-MS - Mark P Molloy, Australia
[MO02-003] iST: Sample Preparation for High Throughput Clinical Proteomics- A Novel, Fast, Sensitive and Reproducible Sample Preparation for MS-Based Proteomics - Garwin Pichler, Germany
[MO02-004] All MS/MS Ions Monitoring Acquired by Data-Dependent Acquisition Without Dynamic Exclusion: A New Concept for In-Depth Protein Quantification - Fei Fang, China
[MO02-005] Analyses of Intact Proteins by LC-FT-ICR Mass Spectrometry at 21 Tesla
Lissa C. Anderson, United States
Keynote Session: Chemical Probes & Chemical Biology for Proteomics
  • Room: 101 C, 1F
[MK-05]Spatially-Resolved Proteomic Mapping in Living Cells Via Enzyme-Mediated Proximity Labeling - Alice Y. Ting, USA
[MK-06] Genetically Encoded Protein Photocrosslinker for Comparative Proteomics - Peng Chen, China
[MO03-001] Quantitative Activity-Based Profiling of Kinase Inhibitor Binding and Selectivity on Protein Microarrays Containing >300 Human Protein Kinases - Jonathan Blackburn, South Africa
[MO03-002] Novel Hybrid Platform for Rapid, Highly Sensitive and Specific Quantification of Proteins and Their Post-Translational Modifications - Liqi Xie, China
[MO03-003] A Highly Sensitive Probe for Fucosylated Glycans for Biomarker Discovery - Naoyuki Taniguchi, Japan
[MO03-004] A novel Set of Isobaric Peptide Labeling Reagent Enabled Proteomic Quantification Over 10 Different Samples - Yan Ren, China
[MO03-005] TMTcalibrator™ Enhances Biomarker Discovery in Peripheral Fluids –
Hui-Chung Liang, United Kingdom
Keynote Session: Metabolomics & Metabolic Disorders
  • Room: 101 D, 1F
[MK-07] Single Cell Metabolomics and Applications - Tsutomu Masujima, Japan
[MK-08] The Role of Gut Microbiota, Bile Acids, Intestinal Farnesoid X Receptor Signaling, and Ceramides in Metabolic Disease - Frank J. Gonzalez, USA
[MO04-001] Global Data Standardization Algorithm for Applied Metabolomics - Petr Lokhov, Russia
[MO04-002] Systemic Proteomic and Metabolomic Analyses Identify Crucial Roles of the Polyol Pathway in Tumorigenesis - Anuli Uzozie, Switzerland
[MO04-003] Urine Proteomics for Evaluation of Taking Nano-Mist Sauna Effects on  the Health - Yoshitoshi Hirao, Japan
[MO04-004] Mass Spectrometry-Based Proteomic and Metabolic Analysis of Different Cell Lines After Perturbation of Cellular Cholesterol Regulation - Peter Blattmann, Switzerland
[MO04-005] imCorrect: New UHRMS Signal Handling Approach for More Accurate Elemental Composition Determination - Wei-Hung Chang, Taiwan
Keynote Session: Brain & EyeOME: Connecting two images
  • Room: 102, 1F
[MK-09] Neuroproteomic Profiling of Proteins and Autoantibody Repertoires in Plasma and CSF - Peter Nilsson, Sweden
[MK-10] Proteomic Approaches to Understanding Age-Related Macular Degeneration -
Richard D. Semba, USA
[MO05-001] Proteomics Reveals Individual Patient Responses to Therapeutic Treatment for Dry Eye - Roger BeuermanSingapore
[MO05-002] A Comprehensive Inter-Grade Proteomic Analysis of Serum, CSF and Tissue in Glioma - Manubhai Kp, India
[MO05-003] Building a Comprehensive Chick Retinal Proteome Dataset by Liquid Chromatography (LC) Fractionation for Tandem MS and SWATH Analysis - Hu Xiao, Hong Kong, China
[MO05-004] Do Platelet-Derived Extracellular Vesicles Contain Specific Biomarkers Allowing for Early Diagnostics of Alzheimer’s Disease? - Helmut Erich Meyer, Germany
[MO05-005] Generating a Proteomic Profile of Neurogenesis, Through a Quantitative Comparison of Neuroepithelial and Radial Glial Like Stem Cells - Shaun Garnett,South Africa
12:30-13:30 Industry Seminar supported by SCIEX:
Applications of Industrialized Quantitative Proteomics to Advance Precision Medicine
  • Room: 101 C, 1F
Industry Seminar supported by Thermo Fisher:
High-Throughput Multiplexed Quantitative Proteomics for Personalized Medicine Applications
  • Room: North Lounge, 3F
Industry Seminar supported by Waters:
Novel Data Independent Acquisition and Processing Strategies for Quantitative Proteomics
  • Room: South Lounge, 3F
Industry Seminar supported by Thermo Fisher:
Sweet Revolution: Analytical Tools for the Characterization of Glycans and Glycoproteins
  • Room: Joy Lounge, 4F
Industry Seminar supported by Agilent:
Advances in Proteomics from Agilent Technologies
  • Room: Elgance Lounge, 4F
Industry Seminar supported by Bruker:
Uncompromised Performance: Exploiting the Potential of UHR-Q-TOF for Discovery Proteomics
  • Room: VIP Room, 4F
Keynote Session: Immunity, Inflammation & Infectious Diseases
  • Room: Plenary Hall, 3F
[MK-11] Proteomics in Viral Infectious Diseases: Global and Targeted Functional Insights into the Virus-Host Interface - Ileana M. Cristea, United States
[MK-12] Immunotherapy of Cancer; An Overview and Recent Results - Donald F. Hunt, United States
[MO06-001] The Human Immunopeptidome: Can Big Data Improve the Precision of Immunotherapy? - Anthony Purcell, Australia
[MO06-002] Quantitative Host-Pathogen Protein Network Analysis Using Data-Independent Acquisition Mass Spectrometry Analysis - Johan Malmström, Sweden
[MO06-003] Proteomic of Host-Microbiome Interactions in a Pediatric Inflammatory Bowel Disease Inception Cohort to Identify Protein Biomarkers - Daniel Figeys, Canada
[MO06-004] Challenges of Biomarker Discovery in Developing Countries: A Proteomics Investigation to Identify Unique Disease Signatures in Infectious Diseases - Sanjeeva Srivastava, India
[MO06-005] Robust Temporal Profiling of GRB2 Protein Complexes in Primary T Lymphocytes Using SWATH Mass Spectrometry - Etienne Caron, Switzerland
Keynote Session: BioInformatics & Computational Proteomics
  • Room: 101 AB, 1F
[MK-13] More Power and More Depth: New Tools for Proteomics Data Processing - Lennart Martens, Belgium
[MK-14] Exploring the Diversity in the Human Proteome - Nuno Bandeira, Unitesd States
[MO07-001] Investigating the Basic Assumptions in Protein Abundance Estimation Using SWATH-MS Data - Wenguang Shao, Switzerland
[MO07-002] Reactome - Interactive Pathway Analysis for Proteomics - Henning Hermjakob, United Kingdom
[MO07-003] MSCypher: A High-Throughput Peptide Identification Strategy for Complex Mixtures - Andrew Webb, Australia
[MO07-004] neXtProt in the Context of Human Proteomics Projects - Lydie Lane, Switzerland
[MO07-005] A Genetic Algorithm to Locate Responsive Subpathways for Time-Course Proteomic Data - Eu-Yu Lai, Taiwan
Keynote Session: PTM Crosstalks I - Phosphoproteomics, Kinome & OGlcNAc
  • Room: 101 C, 1F
[MK-15] Modulation of Multiple PTMs Upon Brief Cellular Stimulation - Martin Larsen, Denmark
[MK-16] Nutrient Regulation of Cellular Physiology by Extensive Crosstalk Between O-GlcNAcylation & Phosphorylation - Gerald W. Hart, United States
[MO08-001] Drug Resistance Assessed by Multi-Proteomics Approaches - Simone Lemeer, Netherlands
[MO08-002] Proteome Dynamics Reveal Temporal Regulation of O-GlcNAcylation/phosphorylation in Determining Apoptosis of Activated B Cells - Hsin-Yi Wu, Taiwan
[MO08-003] Subtilisin for Large Scale (Phospho)Proteomics – the Beginning of a Wonderful Love Story? - Humberto Gonczarowska-Jorge, Germany
[MO08-004] Profiling Kinome Activities Using Kinase-Specific Substrate Peptides - Naoyuki Sugiyama, Japan
[MO08-005] Tyrosine phosphorylation Changes Due to Calcium Signaling Cascade Post-Sampling Prevented by Enzyme Heat Inactivation - Mats Borén, Sweden
Keynote Session: New Technological Advancements
  • Room: 101 D, 1F
[MK-17] Proteomics 2.0:  Recent Advances in Top Down Proteomics - Neil Kelleher, United States
[MK-18] Capturing the Spatial Proteome in Action - Kathryn Lilley, United Kingdom
[MO09-001] Structural Characterization of Protein Phosphorylation and Antibody Complexes by Top/middle-Down Mass Spectrometry - Jingxi Pan, Canada
[MO09-002] Trapped Ion Mobility Spectrometry: An Additional Dimension of Separation for Proteomics Applications - Melvin Park, United States
[MO09-003] Qualitative and Quantitative Characterization of a Novel Scanning Quadrupole DIA Method for Omics Analysis - Johannes Pc Vissers, United Kingdom
[MO09-004] ProteusQC™: the Versatile Standard for Bottom-up Proteomics - Andrew Percy, United States
[MO09-005] Sampling of Tissues for Proteomics by Soft Laser Ablation - Hartmut Schlueter, Germany
Keynote Session: Diabetes and Cardiovascular Diseases: Energy Balance in Disease Phenotypes
  • Room: 102, 1F
[MK-19] Proteomic and Metabolic Health Phenotypes in Dietary Clinical Interventions - Loïc Dayon, Switzerland
[MK-20] Characterization of Protein Dynamics in the Myocardium using Multidimensional Proteomics - Maggie Lam, United States
[MO10-001] Changes in Protein Expression Patterns in Islets of Langerhans: Implications for Treatment of Children with Obesity and Type 2 Diabetes - Peter Bergsten, Sweden
[MO10-002] Proteomic Phenotyping of Human Arterial Samples Identifies Novel Markers of Early Atherosclerosis - David Herrington, United States
[MO10-003] Proteomic Analysis of Membranes in Mouse and Human Cardiovascular Tissues - Anthony Gramolini, Canada
[MO10-004] Glycoproteomics of the Aortic Extracellular Matrix: An Approach for Studying Diabetes and Cardiovascular Risk - Ferheen Baig, United Kingdom
[MO10-005] Phosphoproteomics Identifies CK2 as a Negative Regulator of Beige Adipocyte Thermogenesis and Energy Expenditure - Kosaku Shinoda, United States
[MO10-006] Protective Effects of GLP-1 Analogues Against Cellular Stress: An in Vitro Proteomic Study - Ali Tiss, Kuwait
[MO10-007] Poorly Controlled Diabetes Mellitus is Associated with Decreased Aspirin-Mediated Acetylation of Platelet Cyclooxygenase 1 (COX-1) at Serine 529 - Jean-Charles Sanchez, Switzerland
15:30-16:30 Networking Break and Poster Viewing
[PL 04]
Plenary Session: Proteogenomic Analysis of Cancer: New Opportunities in Cancer Biology and Precision Medicine
  • Room: Plenary Hall, 3F
  • Speaker: Henry Rodriguez, National Cancer Institute, National Institutes of Health, USA
[PL 05]
Plenary Session: Development of Near Complete Proteome Coverage Technology and Its Application on Cell Signaling Study
  • Room: Plenary Hall, 3F
  • Speaker: Fuchu He, Beijing Proteome Research Center, China
18:15-19:15 HUPO General Assembly
  • Room: 101AB, 1F
19:30-21:30 Invited Speaker Dinner (by Invitation Only)
  • Location: Taipei World Trade Center Club, Taipei

TUESDAY SEP. 20, 2016
Click here to download the program.
Registration 08:00-17:30 @Lobby, 1F
Speaker Ready Room 08:00-17:30 @103, 1F
09:00-17:30 Bioinformatics Hub Click here for more information
  • Room: 203, 2F
Plenary Session: Glycoproteomics – A genetic Approach to Deconstruction and Simplification of Protein Glycosylation
  • Room: Plenary Hall, 3F
  • Speaker: Henrik Clausen, Department of Cellular and Molecular Medicine, University of Copenhagen, Denmark
09:30-10:30 Networking Break and Poster Viewing
Keynote Session: Interactomics & Protein Network
  • Room: Plenary Hall, 3F
[TK-01] Membrane Protein Complexes - Jun Qin, China
[TK-02] Multilayer Proteomics Approaches to Understanding Common Human Diseases - Junmin Peng, United States
[TO01-001] The Regulatory Role of Methylation and Methylation–Phosphorylation Crosstalk in Protein Interaction Networks - Marc Wilkins, Australia
[TO01-002] Network Analysis Reveals a Dominant Role of Protein-Level Regulation in Coordinating Gene Functions - Bing Zhang, United States
[TO01-003] Profiling the Phosphotyrosine Interactome of Receptor Tyrosine Kinases - Runsheng Zheng, Germany
[TO01-004] Phylointeractomics Reconstructs Functional Evolution of Protein Binding - Dennis Kappei, Singapore
[TO01-005] Determining Network Topology, Distance Restraints and Activation Markers from Endogenous Protein Complexes - Marco Faini, Switzerland
Keynote Session: Glycoproteomics - Technical Limitations & Prospects
  • Room: 101 AB, 1F
[TK-03] Extracellular Glycosylation: How to see the Forest Despite All the Trees - Katalin F. Medzihradszky, Hungary
[TK-04] Comprehensive Analysis of N-Linked Protein Glycosylation Using NGAG and Mass Spectrometry
Hui Zhang, Johns Hopkins University, United States
[TO02-001] In-depth analysis of human plasma glycoproteins by a combination of high-resolution native mass spectrometry and middle-down proteomics - Vojtech Franc, Netherlands
[TO02-002] Confident, Automated N-Glycoproteomics Profiling in Enriched and Unenriched Cell Samples - Scott Peterman, United States
[TO02-003] Identification of Intact Glycopeptides with In-Silico Deglycosylation Strategy for O-glycoproteomics Analysis - Hongqiang Qin, China
[TO02-004] Glycoproteomic Analysis of Human Plasma Using SWATH-MS - Chi-Hung Lin, Australia
[TO02-005] A Suite of SWATH Glycoproteomic Approaches for Easy global Glycoprotein Analysis - Ben Schulz, Australia
Keynote Session: PTM Crosstalks II - Lysine & other Modificomics
  • Room: 101 C, 1F
[TK-05] Systems-Wide Analysis of Properties and Functions of Lysine Acetylation and Ubiquitylation - Chunaram Choudhary, Denmark
[TK-06] Discovery and Initial Characterization of a Family of Lysine Acylation Pathways - Yingming Zhao, United States
[TO03-001] Unravelling Crosstalks Between SUMOylation and Other Protein Modifications in Human Cells Using Dynamic Proteomics - Pierre Thibault, Canada
[TO03-002] Towards Comprehensive Analysis of Protein ADP-ribosylation - Yonghao Yu, United States
[TO03-003] Acetylome Analysis Reveals Carbon Metabolism as a Key Factor Enhancing Thermogenesis in White Adipocytes - Hsin-Yi Chang, Japan
[TO03-004] Effects of Co-/Post-Translational Modifications on Protein Function - Hisashi Hirano, Japan
[TO03-005] Efficient Enrichment of SUMOylated Peptides from Alpha-Lytic Protease Digest Using K- Ɛ -GG Remnant Immuno-Affinity Purification - Hongbo Gu, United States
Keynote Session: Imaging Mass Spectrometry
  • Room: 101 D, 1F
[TK-07] Peptide and Glycan Mass Spectrometry Imaging as Diagnostic Tool in Cancer Research - Peter Hoffmann, Australia
[TK-08] Molecular Imaging of the Brain by Mass Spectrometry - Per Andrén, Sweden
[TO04-001] Molecular Imaging of Protein in Tissues Using Ambient Ionization Top-Down Mass Spectrometry - Cheng-Chih Hsu, Taiwan
[TO04-002] 3D MALDI Imaging Mass Spectrometry Using Next Generation Technologies - Reconstruction of a Molecular Imaged Epididymis - Charles Pineau, France
[TO04-003] Localization and Identification of Peptides from Tissue Using High-Speed MALDI TOF/TOF Mass Spectrometry - Sabu Sahadevan, France
[TO04-004] Monitoring ErbB1 and ErbB2 Interaction and Activation Using Engineered Cell Lines and Duolink Proximity Ligation Assay by High-Content Imaging - Tracy Adair-Kirk, United States
[TO04-005] Molecular Profile Discrimination and Mapping of Skeletal Muscle Regeneration in Rat Crush Model Using MALDI Imaging - Anne Denys, France
Keynote Session: Liver & Toxicoproteomics: Metabolism, Drug Transformation & Toxicity
  • Room: 102, 1F
[TK-09] Systematic Analysis of One Carbon Metabolism by SRM. Implications in the Progression of Chronic Liver Disorders - Fernando J. Corrales, Spain
[TK-10] Drug-Drug Interaction: Monitoring CYP450 enzymes and Transporters in Mice and Men - Oliver Poetz, Germany
[TO05-001] Personalized proteomic characterization of hepatitis B virus-associated hepatocellular carcinomas - Ying Jiang, China
[TO05-002] In vitro investigation of an adverse outcome pathway of cholestatic liver injury using quantitative phosphoproteomics - René Zahedi, Germany
[TO05-003] Differential proteomic analysis of cholangiocarcinoma cells and cell-derived extracellular vesicles by label free mass spectrometry - Felix Elortza, Spain
[TO05-004] Proteome analysis of microdissected tumor cells reveals Annexin A10 as biomarker candidate for differentiation of ICC and liver metastases of PDAC - Thilo Bracht, Germany
12:30-13:30 Industry Seminar supported by SCIEX:
IInnovations in Industrializing Quantitative Proteomics
  • Room: North Lounge, 3F
Industry Seminar supported by Bruker:
Answering the Proteoforms Challenge: Alternative Approaches for Biomarker Discovery Room: South Lounge, 3F
Industry Seminar supported by Meridigen:
Discovery and Future Application for Mesenchymal Stem Cell
  • Room: Joy Lounge, 4F
Industry Seminar supported by MERCK:
Verify the Protein Interactome with Visual Confirmation
  • Room: Elgance Lounge, 4F
Industry Seminar supported by Thermo Fisher:
Defining biological phenotypes by quantifying small molecular changes
  • Room: VIP Room, 4F
Keynote Session: Antibodies & Protein Arrays
  • Room: Plenary Hall, 3F
[TK-11] Application of Protein Microarrays in Epigenetics and Drug Discovery - Heng Zhu, United States
[TK-12] Validation of Antibodies to Study the Human Proteome - Mathias Uhlén, Sweden
[TO06-001] Status of the Affinity Binder Knockdown Initiative - Tove Alm, Sweden
[TO06-002] Heterogeneous Ribonucleoprotein K (hnRNP K) Binds the 5' Terminal Sequence of the Hepatitis C Virus RNA and Mature miR-122 - Chien-Sheng Chen, Taiwan
[TO06-003] A High-Content Functional Mycobacterium Tuberculosis Proteome Microarray and Its Applications - Yang Li, China
[TO06-004] Utilizing Protein Microarray to Monitor Blood-Brain Barrier Disruption and Active Inflammation in Plasma Samples from Multiple Sclerosis Patients - Malene Moeller Joergensen, Denmark
[TO06-005] Mapping Transcription Factor Interactome Networks Using HaloTag Protein Arrays - Junshi Yazaki, Japan
Keynote Session: Integrative Glyco(proteo)mics for Glycobiology & Diseases
  • Room: 101 AB, 1F
[TK-13] Advances in Glycoproteomics Facilitate the Discovery of a New Class of Functionally Important Cancer and Inflammation-Centric Human Glycoproteins - Morten Thaysen-Andersen, Australia
[TK-14] Accurate Mass- and Glycan Composition-Based Assignment of Glycosylation Site-Specific Glycomes of Complex Glycoprotein Mixture - Hiroyuki Kaji, Japan
[TO07-001] Identification of Intact Glycopeptides at a Proteome Scale - Mingqi Liu, China
[TO07-002] Integrated Glycoproteomics Demonstrates Fucosylated Serum Paraoxonase 1 Alterations And functions in Lung Cancer - Je Yoel Cho, South Korea
[TO07-003] Decoding Site-Specific Alteration of Sialo-Glycoproteome in EGFR-Subtype of Non-Small Cell Lung Cancer - Yi-Ju Chen, Taiwan
[TO07-004] Identifying Antibody and Lectin Recognition to HIV N-Glycans Through Native Mass Spectrometry and Glycoproteomic Analysis of Viral Envelope Spikes - Weston Struwe, United Kingdom
[TO07-005] Dynamic mapping of Human Frontal Cortex According to the Developmental Stage via Neuroglycomic Approach - Jua Lee, South Korea
Keynote Session: Proteome Dynamics:Stability, Turnover & Degradomics
  • Room: 101 C, 1F
[TK-15] Positional Proteomics Technologies to Functionally Annotate Tissue Proteomes in Pathology - Christopher Overall, Canada
[TK-16] Ubiquitin Proteomics – Revelations of a Master Manipulator - Donald Kirkpatrick, United States
[TO08-001] Copy Number Alteration Programmed Protein Turnover Quantified by pSILAC and SWATH Mass Spectrometry - Yansheng Liu, Switzerland
[TO08-002] High Resolution Mass Spectrometry Cellular Thermal Shift Assay (HR-MS-CETSA) - Post-Translational Modifications Impact on Protein Stability - Radoslaw Sobota, Singapore
[TO08-003] A Dynamic Picture of the Proteome and Ibiquitinome Upon Proteasome Inactivation - Jeroen Demmers, Netherlands
[TO08-004] Proteome Turnover Analysis Reveals Substrates and Physiological Role of Membrane Proteases - Ansgar Poetsch, Argentina
[TO08-005] A Novel Function of CRL2 Ubiquitin Ligase in Protein Quality Control - Hsiu-Chuan Lin, Taiwan
Keynote Session: Spatial & Single Cell Proteomics
  • Room: 101 D, 1F
[TK-17] The Human Cell Atlas - Emma Lundberg, Sweden
[TK-18] Analysis of Tumor Heterogeneity in Three Dimensions by Imaging Mass Cytometry - Bernd Bodenmiller, Switzerland
[TO09-001] Quantitative Proteome-Wide Profiling of the Retromer Cargo Landscape - Christina Bell, United States
[TO09-002] Refining the Details in the Tissue-Based Map of the Human Proteome - Cecilia Lindskog, Sweden
[TO09-003] Membrane Localization of Metabolic Enzymes and Metabolic Modulation in a Cell Division Mutant of Escherichia Coli Identified by Omics Approaches - Yu-Ling Shih, Taiwan
[TO09-004] Determining Post-Translational Modifications of Nuclear Proteins - Ryotaro Ban, Japan
[TO09-005] Single-Cell Proteome Profiling: Innovations in Sample Preparation - Masaki Wakabayashi, Japan
Keynote Session: Protein Standards and Model Organisms: Expanding Our Horizons
  • Room: 102, 1F
[TK-19] Recent Progress and New Projects for the HUPO Proteomics Standards Initiative - Eric Deutsch, United States
[TO10-001] - The ProteomeXchange Consortium: 2016 update - Juan Antonio Vizcaino, United Kingdom
[TO10-002] proBAMconvert: Organizing MS Identifications in a Genome-Centric Fashion Enables Proteogenomics and Proteomics Integration - Gerben Menschaert, Belgium
[TO10-003] The HUPO-PSI Quality Control Working Group: Making QC More Accessible for Biological Mass Spectrometry - Mathias Walzer, Germany
[TK-20] The Golgi Localized UDP-GlcNAc Transporter is Required for the Maturation of Complex N-glycans in Plants - Joshua Heazlewood, Australia
[TO10-004] Adipose Tissue Pathways in Obesity: Iberian Pig as Large Animal Model of Metabolic Disorders - Cristian Piras, Italy
[TO10-005] Proteomics in Food Safety: Monitoring Competition between Listeria Monocytogenes and Lactococcus Lactis by Imaging Mass Spectrometry - Isabella Alloggio, Italy
[TO10-006] Proteome Alterations in the Porcine Endometrium during Embryo Implantation - Thomas Fröhlich, Germany
15:30-16:30 Networking Break and Poster Viewing
15:30-16:30 PhD Abstract Competition
  • Room: 201, 2F
[PL 06]
Plenary Session: Complementary Methods for Probing Protein Assemblies and Interactions
  • Room: Plenary Hall, 3F
  • Speaker: Albert J Heck, Utrecht University and Netherlands Proteomics Centre, The Netherlands
18:00-21:00 HUPO Congress Night: Formosa Night [Ticket Event]
  • Location: 14F, Taipei New Horizon

Click here to download the program.
Registration 08:00-16:00 @Lobby, 1F
Speaker Ready Room 08:00-16:00 @103, 1F
Plenary Session: Precision Medicine: Proteomics in the Context of Health Assessment and Systems Biology
  • Room: Plenary Hall, 3F
  • Speaker: Jennifer Van Eyk, Cedars Sinai Medical Center, United States
09:00-17:30 Bioinformatics Hub Click here for more information
  • Room: 203, 2F
09:30-10:15 ECR Manuscript Competition
  • Room: 102, 1F
09:30-10:30 Networking Break and Poster Viewing
  • Exhibition & Poster: 201, 2F / Banquet Hall, 3F
10:30-15:30 Bioinformatics Hub Special Interest Topic: Glycoproteomics Informatics
  • Room: 203, 2F
Keynote Session: Pharmacoproteomics & Drug Development
  • Room: Plenary Hall, 3F
[WK-01] Kinase-Centric Pharmacoproteomics for Molecular-Targeting Drug Discovery - Yasushi Ishihama, Japan
[WK-02] Quantitative Proteomics To Support the Discovery and Development of Targeted Drugs - Henrik Daub, Germany
[WO01-001] Proteome-Wide Drug Dose-Response of Prostate Cancer Cell Lines Exposed to Androgen Receptor Antagonists by Microflow-LC SWATH MS Analysis - Christie Hunter, United States
[WO01-002] Profiling Changes in the Phosphoproteome of Hematopoietic Cells in Response to a Novel Class of Anti-Oncogenic Compounds - Peter Kubiniok, Canada
[WO01-003] Cancer Proteomics towards Precision Medicine by Molecular Targeting Drug - Zhiwei Qiao, Japan
[WO01-004] Drug Development by Linking Pathophysiology in Cancer to Proteomics - Marko-Varga György, Sweden, Japan
Keynote Session: Proteogenomics & The Missing Proteins
  • Room: 101 AB, 1F
[WK-03] A Novel Data-Independent Acquisition (DIA) Mass Spectrometry Approach Integrated With RNA-Seq for Deep Proteogenomic Profiling - Akhilesh Pandey, United States
[WK-04] A Proteogenomic Analysis of Early Onset Gastric Cancer - Daehee Hwang, South Korea
[WO02-001] A Proteogenomics Approach to Reveal Molecular Mechanisms of COPD - Peter Horvatovich, Netherlands
[WO02-002] Launch of MissingProteinPedia: Accelerating Discovery of the Human Proteome Project’s “Missing Proteins” - Mark S Baker, Australia
[WO02-003] Proteogenomics of Human Cancer Cell Lines: Coding Variants Identified by Shotgun Proteomics - Sergei Moshkovskii, Russia
[WO02-004] Proteogenomic Profiling of Neoantigens for Personalized Cancer Immunotherapy - Koji Ueda, Japan
[WO02-005] Missing Genes and Supplementary Tissues in the Human Protein Atlas - Evelina Sjostedt, Sweden
Keynote Session: Cysteine Modifications & Redoxomics
  • Room: 101 C, 1F
[WK-05] Proteomic-Scale Approaches for Identifying Reversible and Irreversible Cysteine Redox PTM in Myocardial Ischemia / Reperfusion - Stuart Cordwell, Australia
[WK-06] ROSics: Principle of ROS in Oxidative Modifications and Structural Regulations  - Kong-Joo Lee, South Korea
[WO03-001] Quantitative Proteomics Depicts the Landscape of Cysteine Redoxome for Nitric Oxide-Mediated Myocardial Protection against Ischemia-Reperfusion Injury - Tzu-Ching Meng, Taiwan
[WO03-002] Proteomic Analysis of S-sulfhydration by Ultrafilter-Assisted Functional Supramolecular Polymer Capture - Huiming Yuan, China
[WO03-003] TRPC6-dependent S-nitrosylation in Duchenne Muscular Dystrophy - Heaseung Sophia Chung, United States
[WO03-004] Proteomic and Redox Proteomic Analyses Reveal a Dual ROS-Regulation of Glucose Uptake in Adipocytes - Zhiduan Su, Australia
[WO03-005] Identification of Protein Estrogenization as a Redox Post-Translational Modification by Shot-Gun Proteomics and Activity Probe with Dimethyl Labeling - Shu-Hui Chen, Taiwan
Keynote Session: Membrane & Extracellular Proteomics
  • Room: 101 D, 1F
[WK-07] Decoding Ligand Receptor Interactions -Bernd Wollscheid, Switzerland
[WK-08] Targeting Epidermal Growth Factor Receptor (EGFR) in Lung Cancer: Towards Interactome-Informed Medicine - Igor Stagljar, Canada
[WO04-001] Analysis of Plasma Membrane Proteomes of Gastric Cancer Cells Reveals that ASCT2 is Involved in Cancer Metastasis by Targeting WNT/b-catenin Signaling - Feng Liu, China
[WO04-002] Tumour-Dependent Fibroblast Activation: When a Good Neighbour Turns Bad - Wei Wu, Netherlands
[WO04-003] Analysis of Proteoforms in Membrane Protein Complexes by CID/ETD Top-Down Proteomics - Hans Wessels, Netherlands
[WO04-004] In Silico Characterization of the Human Lipid Raft Proteome - Michelle Hill, Australia
[WO04-005] Exosomal EphA2 Transmits Chemoresistance and Predicts Pancreatic Cancer Patient Responses to Therapy - Tony Hu, United States
[WO04-006] Systemic Perturbation of Keratinocyte Homeostasis by Genetic Loss of the Extracellular Matrix Protein Collagen VII - Kerstin Thriene, Germany
Keynote Session: Food & Nutrition and Immuno- Peptidome: Focus on Food Allergies
  • Room: 102, 1F
[WK-09] Food and Nutrition Proteomics: Focus on Food Allergens and Allergies - Paola Roncada, Italy
[WK-10] The Human Immuno-Peptidome Project: A New Initiative of B/D-HPP Program - Etienne Caron, Switzerland
[WO05-001] The Benefits of Hybrid Fragmentation Technologies (EThcD) for Analysing the Immunopeptidome - Albert J Heck, The Netherlands
[WO05-002] Digestomics of Raw Peanut and Characterization of Gastric-Phase Released Peptides of Peanut Allergens - Tanja Cirkovic Velickovic, Serbia
[WO05-003] Ultra-Fast Analysis of Allergens Using Capillary Electrophoresis Coupled to Mass Spectrometry and Ultraviolet Photodissociation - Daniel Lopez-Ferrer, United States
[WO05-004] Characterisation of Specificity of Different Commercial Proteases for Food Hydrolysates - Cristian De Gobba, Denmark
[WO05-005] Characterization and Modulation of Fish Allergens - Pedro Rodrigues, Portugal
12:30-13:30 Networking Break and Poster Viewing
  • Exhibition & Poster: 201, 2F / Banquet Hall, 3F
Keynote Session: Chemical Proteomics & Drug Profiling
  • Room: Plenary Hall, 3F
[WK-11] Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors - Bernhard Kuster, Germany
[WK-12] Thermal Proteome Profiling for Drug Discovery - Mikhail Savitski, Germany
[WO06-001] Target Identification in Living Cells via Mass Spectrometry-Based Chemical Proteomics - Xuezhi Bi, Singapore
[WO06-002] Comprehensive Mass Spectrometry Analysis Identifies a Novel Therapeutic Target in the Wnt Signaling Pathway - Tesshi Yamada, Japan
[WO06-003] The Phosphoproteome of the NCI-60 Cell Line Panel Reveals Markers of Drug Sensitivity - Chen Meng, Germany
[WO06-004] Targeted Proteomic Profiling of Enzymes that Activate the Prodrug PR-104A in Human Leukaemias - Yongchuan Gu, New Zealand
[WO06-005] Identification of TIFA as a Novel Therapeutic Target in Acute Myeloid Leukemia - Tong-You Wei, Taiwan
Keynote Session: Proteomics in the Era of Big Data
  • Room: 101 AB, 1F
[WK-13] Precision Analysis of Proteome by HPLC-ESI-MS - Pengyuan Yang, Fudan University, China
[WK-14] Data Infrastructure for Chinese Human Proteome Project - Weimin Zhu, National Institute for Protein Sciences – Beijing, China
[WO07-001] Leaving Shallow Waters of Protein Identification: Integrating Taxonomic and Functional Information to Tackle Challenges in Metaproteomic Data Analysis - Thilo Muth, Germany
[WO07-002] HUPO Human Proteome Project Metrics for 2016 - Gilbert Omenn, United States
[WO07-003] Quantitation and Evaluation of Candidate Biomarkers of Pancreatic Cancer in Plasma Using Multiple Reaction of Monitoring Method - Weimin Zheng, China
[WO07-004] ProDiGy: a Proteome Knowledge Discovery Gateway - Dong Li, China
[WO07-005] Comprehensive Draft of the HeLa Proteome to a Depth of More than 13,000 Proteins - Dorte Breinholdt Bekker-Jensen, Denmark
Keynote Session: Neurological Disorders & Neuroproteomics
  • Room: 101 C, 1F
[WK-15] Employing Neuroproteomics to Understand the Molecular Basis of Schizophrenia - Daniel Martins-de-Souza, Brazil
[WK-16] Exploring the Role of Hydrogen Sulfide in Neurodegenerative Disorders - Andrea Urbani, Italy
[WO08-001] Gene Expression and Proteomic Analysis of Cognitive Dysfunction in People with Remitted Major Depression - Klaus Oliver Schubert, Australia
[WO08-002] Proteomic Dissection of AMPA Receptor Complexes Identifies FRRS1l as a Determinant for Receptor Biogenesis Mutated in Severe Intellectual Disability - Uwe Schulte, Germany
[WO08-003] Autoantibody Response in Meningioma Patients Reveals Aberrations in Signalling Pathways - Shabarni Gupta, India
[WO08-004] Proteomic Analysis of Motor Neurons from Induced Pluripotent Stem Cells: ALS - Victoria Dardov, United States
[WO08-005] Analysis of the O-GlcNAcomic Profiling of Brain Tissue in Alzheimer’s Disease - Wei-Wei Chang, Taiwan
Keynote Session: Plant & Microbial Proteomics
  • Room: 101 D, 1F
[WK-17] Using Proteomic Tools to Reveal New Facets of Plant Signaling - Weiguo Andy Tao, United States
[WK-18] Application of Mass Spectrometric Technology for Quantifying Changes in Plasma Membrane Receptor-Mediated Signaling in Arabidopsis Thaliana - Michael R. Sussman, United States
[WO09-001] Quantitative Proteomic Analysis of Flooding and Its Recovery in Soybean Exposed to Aluminum Oxide Nanoparticles - Setsuko Komatsu, Japan
[WO09-002] Single-Species Proteomics, Multi-Species Metaproteomics, Trends and Opportunities to Read-Across in Environmental Assessment - Susana Cristobal, Sweden
[WO09-003] Gastric Bypass Surgery Clearly Perturbs the Community Structure and the Functional Composition of the Intestinal Microbiota - Nico Jehmlich, Germany
[WO09-004] Integrated Extracellular Matrix Proteome And organ Specific Transcriptome Decipher Cell Wall Mediated Immunity in Plant - Kanika Narula, India
[WO09-005] Phosphoproteomic Analysis of Abscisic Acid Signaling Components in Arabidopsis Seed - Anna Amagai, Japan
Keynote Session: Kidney, Urine and Plasma: Opportunities for early diagnosis and risk assessment
  • Room: 102, 1F
[WK-19] Social Implementation Vision of All-In-One Urine Test for Health Checkups - Tadashi Yamamoto, Japan
[WK-20] Affinity Proteomics with Plasma Biobanks - From Discovery to Validaon - Jochen Schwenk, Sweden
[WO10-001] Comparative Proteomic Analysis of Kidney Distal Convoluted Tubule and Cortical Collecting Duct Cells Following Long-Term Hormonal Stimulation - Qi Wu, Denmark
[WO10-002] Targeted MS-based Assay of Circulating Proteoforms Related to Aging in Human Plasma - Pingbo Zhang, United States
[WO10-003] Can Proteomics Contribute to Solving the Riddle of Diabetic Nephropathy? - Leena Kerstin Maria Liljedahl, Sweden
[WO10-004] Quantification of Angiotensin II-Regulated Proteins in Urine of Patients with Polycystic and Chronic Kidney Diseases by Selected Reaction Monitoring - Ana Konvalinka, Canada
[WO10-005] Analysis of the HDL Proteome - Myths and Legends and Reality - Manfred Raida, Singapore
15:30-17:30 Closing Plenary Session with Award Lectures
  • Room: Plenary Hall, 3F
18:00 Transfer to Sun Moon Lake

THURSDAY SEP. 22, 2016 - HPP Post-Congress Day
Location: Cosmos Cloud B (3F), Fleur de Chine Hotel
Click here to download the program.
08:30 Highlights from Congress and discussions of B/D, C-HPP, Resource Pillars
Moderators: Gil Omenn, Young-Ki Paik, Jennifer van Eyk
09:00 Bioinformatics Hub, JPR special issue 2016 and future, experience with HPP MS Guidelines v2.1.
Eric Deutsch, ISB, USA and Chris Overall, Univ. British Columbia, Canada
09:30 Open discussion about recent strategic successes and strategic planning for next year and for 5 years: aims, directions, changes, deliverables
10:00 Coffee Break
10:20 HPP Plenary Lecture 3: Lung Cancer Genomics
Sung-Liang Yu, National Taiwan University, Taiwan
10:50 Reports on the Cluster Meeting (C- & B/D-HPP+CPTAC)
(1) Cancer
(2) In Vitro Transcription/Translation Platform
(3) Reproductive Biology
(4) Membrane Proteins
(5) Neurodegenerative Disease
12:30 Lunch
13:30 HPP Strategy Session
Strategic Evaluation by members of HPP SAB, led by Cathy Costello, Naoyuki Taniguchi, Mathias Uhlen, John Yates
14:30 Communications, Publications, Resources
Publications, including assessment of 2016 JPR special issue and plans for 2017, HPP Operations & Communication matters (C. Pineau, C. Borchers), HPP Resources and Funding, Upcoming Workshops and Meetings: Brazil, 10-12 Dec 2016; joint C-HPP Workshop with EuPA (June, 2018, Spain)
16:00-18:00 Boad Tour

Program at a Glance
Please find a tentative “Program at a Glance” below. The congress program will continue to be updated as speakers and sessions are confirmed.

SUNDAY, SEP. 18, 2016

MONDAY, SEP. 19, 2016

TUESDAY SEP. 20, 2016


Congress Program Plenary Sessions Keynote SessionsIndustry SeminarsPre-Congress Workshop Call for AbstractsAwards ApplicationInformation for Speakers and Poster PresentersAOHUPO 2016